EC approves KTE-X19 for treatment of mantle cell lymphoma
KTE-X19, an investigational CAR T-cell therapy, has been granted marketing authorisation by the European Commission.
List view / Grid view
KTE-X19, an investigational CAR T-cell therapy, has been granted marketing authorisation by the European Commission.
An inspection at a manufacturing facility belonging to Health Pharma has revealed breaches of cGMP regulations, causing the FDA to send a warning letter.
Researchers have revealed that small- and medium-sized companies will by key in the growth of the life sciences sector in Scotland.